-
Signature
-
/s/ Donald Shum, as attorney-in-fact for Karen Akinsanya
-
Stock symbol
-
SDGR
-
Transactions as of
-
Oct 15, 2021
-
Transactions value $
-
-$71,614
-
Form type
-
4
-
Date filed
-
10/19/2021, 05:00 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
SDGR |
Common Stock |
Options Exercise |
$6.05K |
+1.39K |
|
$4.34* |
1.39K |
Oct 15, 2021 |
Direct |
F1 |
transaction |
SDGR |
Common Stock |
Sale |
-$77.7K |
-1.39K |
-100% |
$55.75 |
0 |
Oct 15, 2021 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
SDGR |
Stock Option (right to buy) |
Options Exercise |
$0 |
-1.39K |
-3.12% |
$0.00 |
43.2K |
Oct 15, 2021 |
Common Stock |
1.39K |
$4.34 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
EVP, Chief Biomedical Scientist, Head of Discovery R&D